4//SEC Filing
Anderman Jonathan 4
Accession 0001171843-26-000051
CIK 0001738021other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:32 PM ET
Size
7.8 KB
Accession
0001171843-26-000051
Insider Transaction Report
Form 4
Anderman Jonathan
General Counsel
Transactions
- Award
Common Stock
2026-01-02$5.17/sh+150,000$775,500→ 171,000 total - Award
Stock Option (Right to Buy)
2026-01-02+720,000→ 720,000 totalExercise: $5.17Exp: 2036-01-02→ Common Stock (720,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027.
- [F2]150,000 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.
- [F3]The options vest over 48 substantially equal monthly installments starting February 2, 2026.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0002032625
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:32 PM ET
- Size
- 7.8 KB